What Does Exelixis Do?

Total employees1482
HeadquartersAlameda
Founded1994

Exelixis is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative cancer treatments. The company focuses on therapies for challenging cancers, aiming to improve patient outcomes and quality of life. Key products include CABOMETYX® (cabozantinib) and COMETRIQ® (cabozantinib). Exelixis is driven by a commitment to scientific excellence and a patient-centric approach, continually advancing its pipeline of potential new medicines and exploring new therapeutic targets in oncology.

Where Is Exelixis's Headquarters?

HQ Function

Serves as the central hub for corporate operations, research and development (R&D), drug discovery, clinical development, and administrative functions.

Notable Features:

Modern laboratory and office spaces designed to foster collaboration and scientific innovation. Located in the Harbor Bay Business Park, offering a campus-like environment with waterfront views.

Work Culture:

A dynamic, science-driven, and collaborative work environment focused on tackling challenging diseases. Employees are driven by a shared mission to make a meaningful difference in the lives of patients with cancer.

HQ Significance:

The Alameda headquarters is critical for Exelixis's strategic decision-making, scientific discovery, and overall operational management, leveraging the rich talent pool and biotech ecosystem of the Bay Area.

Values Reflected in HQ: The headquarters' advanced R&D facilities and collaborative workspaces embody Exelixis's commitment to scientific innovation, excellence, and its patient-centric mission.

Location:

Exelixis's primary commercial focus is the United States. Internationally, the company extends the reach of its therapies through strategic collaborations and licensing agreements with pharmaceutical partners for development and commercialization ex-U.S. Exelixis conducts global clinical trials and maintains a growing international operational footprint to support these trials, medical affairs, and regulatory interactions in key regions like Europe.

Street Address:

1851 Harbor Bay Parkway

City:

Alameda

State/Province:

California

Country:

USA

Where Else Does Exelixis Operate Around the World?

The Woodlands, Texas, USA

Address: Office space located in The Woodlands, specific street address not publicly listed.

Strategically positioned to manage and expand commercial activities and healthcare professional engagement across the United States, leveraging talent in a key Texas business hub.

Zug, Switzerland

Address: Dammstrasse 19, 6300 Zug, Switzerland

Provides a strategic presence in Europe, facilitating engagement with European regulatory bodies, partners, and the medical community, and supporting Exelixis's international activities and expansion efforts.

Buying Intent Signals for Exelixis

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Exelixis? Meet the Executive Team

As of April 2025, Exelixis' leadership includes:

Michael M. Morrissey, Ph.D. - President and Chief Executive Officer
Christopher J. Senner - Executive Vice President and Chief Financial Officer
Vicki L. Goodman, M.D. - Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer
P.J. Haley - Executive Vice President, Chief Commercial Officer
Peter Lamb, Ph.D. - Executive Vice President, Scientific Strategy and Chief Scientific Officer
Jeffrey J. Hessekiel, J.D. - Executive Vice President, Chief Business Officer and General Counsel
Dana Aftab, Ph.D. - Executive Vice President, Discovery Research

Who's Investing in Exelixis?

Exelixis has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock Inc.
State Street Global Advisors (SSgA)
Renaissance Technologies LLC
Wellington Management Company LLP

What Leadership Changes Has Exelixis Seen Recently?

Hire2
Exits1

Over the past year, Exelixis has experienced key leadership changes, including the strategic appointment of a new head for Development Operations and a planned transition for the Chief Medical Officer role, reflecting ongoing evolution in its executive team.

Departures

Gisela Schwab, M.D., Dr. Gisela Schwab retired from Exelixis, concluding her long-standing leadership in product development and medical affairs.

New Appointments:

Amy Peterson, M.D., Dr. Amy Peterson joined Exelixis as EVP, Development Operations, bringing extensive experience to the role.
Vicki L. Goodman, M.D., Dr. Vicki L. Goodman was promoted to the role of EVP, Product Development & Medical Affairs, and Chief Medical Officer.

What Technology (Tech Stack) Is Used byExelixis?

Discover the tools Exelixis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Exelixis Email Formats and Examples

Exelixis commonly utilizes an email format combining the employee's first initial with their last name, followed by the @exelixis.com domain. While this is the most prevalent pattern, variations might exist within the organization.

[first_initial][last]@exelixis.com

Format

jdoe@exelixis.com

Example

90%

Success rate

What's the Latest News About Exelixis?

Exelixis, Inc. / Business WireMay 7, 2024

Exelixis Reports First Quarter 2024 Financial Results and Provides Corporate Update

Exelixis announced its financial results for the first quarter of 2024, highlighting revenue performance from its cabozantinib franchise and outlining progress in its clinical development pipeline and corporate objectives....more

Exelixis, Inc. / Business WireJune 3, 2024

Exelixis Announces Presentation of Data for Multiple Cabozantinib-Based Regimens and Pipeline Programs at ASCO 2024

Exelixis showcased new clinical data and trial updates for cabozantinib combinations and its pipeline assets at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, underscoring ongoing research efforts....more

Exelixis, Inc. / Business WireFebruary 20, 2024

Exelixis Appoints Amy Peterson, M.D., as Executive Vice President, Development Operations

Exelixis strengthened its leadership team with the appointment of Dr. Amy Peterson to oversee its clinical development operations, leveraging her extensive experience in oncology drug development....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Exelixis, are just a search away.